NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/06/2024
Back to search
Official data from USPTO
GIBSON ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
11/06/2024
Trademark type
Combined
Nice classes
42
Filing date
08/29/2018
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/06/2024
Last transaction
11/06/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
08/21/2018
First use in commerce
08/21/2018
Drawing code
3
Owner type
16
Owner location
Miami Beach, FL, US
Examiner
BAL, KAMAL SINGH
Current location
Historical data usage
Mark description
The mark consists of the literal element "GIBSON ONCOLOGY" with the first letter "O" of the word "ONCOLOGY" as a ribbon with the ends facing downward and crossing.
Holders and representatives
Holders
Gibson Oncology, LLC
Representatives
Kevin M. Bovard BAKER & HOSTETLER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services performed for others in the fields of drug discoverydrug discovery productspharmaceuticalsmedicinal diagnosticsbiological products; product development consultation in the field of pharmaceutical and biological products
Publications
History of USPTO decisions and trademark events.
24 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/05/2024
E815
TEAS SECTION 8 & 15 RECEIVED
05/16/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/13/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/13/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/13/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/13/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2019
ALIE
ASSIGNED TO LIE
01/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2018
NWAP
NEW APPLICATION ENTERED
09/01/2018
Continuous trademark protection
Get notified about every new filing that threatens GIBSON ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.